Approximately 96% of SMA patients show homozygous deletions of exon 7 and 8 or only of exon 7 of SMN1, making genetic testing fast and neonatal screening highly reliable (reviewed by [7,8]). Here, SMN1 is linked to proximal spinal muscular atrophy.